Bridgeport Hospital launches Aquablation therapy for enlarged prostate
Bridgeport Hospital in Connecticut has introduced Aquablation therapy, a minimally invasive robotic-assisted procedure for men with benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. The first procedures were performed following the program's launch in July 2026, according to the hospital.
The treatment uses advanced imaging, robotics, and a high-velocity, heat-free waterjet to remove excess prostate tissue. It is designed to provide long-lasting symptom relief while reducing certain side effects associated with traditional surgery, per the hospital.
"For many men, symptoms of an enlarged prostate gradually become something they simply learn to live with," said Steven Kardos, MD, chief of Urology at Bridgeport Hospital, in a statement. "Aquablation gives us an important new option to help patients find lasting relief while preserving quality of life."
Anne Diamond, DBA, JD, president of Bridgeport Hospital, noted the hospital's ongoing evaluation of new technologies. The addition reflects Yale New Haven Health's commitment to advanced care across the BPH spectrum, from diagnosis to surgical treatment, the hospital said.